Increase/Decrease in Cash: The total change in cash for the company over the given period.
Yarrow Bioscience, Inc (YARW) had Increase/Decrease in Cash of $-1.10M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.10M |
|
$-3.01M |
|
-- |
|
$0.10M |
|
$3.20M |
|
$-3.10M |
|
$0.20M |
|
$-2.90M |
|
$-2.90M |
|
$-2.90M |
|
$-2.90M |
|
$-3.01M |
|
$-2.90M |
|
$-3.10M |
|
$-3.10M |
|
0.86M |
|
0.86M |
|
$-3.51 |
|
$-3.51 |
|
| Balance Sheet Financials | |
$23.53M |
|
$0.08M |
|
$0.08M |
|
$23.60M |
|
$1.54M |
|
-- |
|
-- |
|
$1.54M |
|
$22.06M |
|
$22.06M |
|
$22.06M |
|
0.67M |
|
| Cash Flow Statement Financials | |
$-6.07M |
|
$5.00M |
|
$-0.03M |
|
$24.03M |
|
$22.93M |
|
|
Increase/Decrease in Cash |
$-1.10M |
$0.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3197.94% |
|
-3197.94% |
|
-- |
|
-2988.66% |
|
-3100.00% |
|
$-6.07M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-13.14% |
|
-13.14% |
|
-12.28% |
|
-13.14% |
|
$33.03 |
|
$-7.08 |
|
$-7.08 |
|